ESR1 and breast cancer: We also identified threonine 116 as one of the Sox2 phosphorylation sites and thus, we believe that detection of phosphorylated-Sox2T116 holds the potential of serving as a potential marker of stem-like cells in estrogen receptor-positive BC.